Research & Development
At TJL Pharmaceutical, we believe that investing in Research and Development is crucial to our mission of improving healthcare in Afghanistan and beyond. Our R&D department is staffed with experienced scientists, pharmacists, and other experts who are dedicated to discovering and developing new medicines and treatments to address some of the most pressing health challenges facing our region.
TJL GROUP OF COMAPNY appoints Aziz Ullah Ph.D., as Head of R&D and chief scientific officer.
Aziz Ullah, Ph.D.
Organic Chemistry
Head of R&D,
Chief scientific officer.
Our Process
We bring science and innovation together
Our R&D team works tirelessly to identify and evaluate potential new drug candidates, and to advance those with the most promising results through the rigorous testing and approval processes required to bring new treatments to market. We also invest in ongoing research into the safety and efficeancy of our existing products, constantly seeking ways to improve and enhance the benefits they provide to our patients.
Clinical Development
Regulatory & Access
Biotech
Functional Service
In addition to our in-house R&D capabilities, we also collaborate with leading academic institutions and research organizations around the world to stay at the forefront of medical innovation. Through these partnerships, we are able to access cutting-edge technologies, tap into diverse expertise and perspectives, and leverage the latest scientific insights to develop new solutions that can make a real difference in the lives of our patients.
Overall, our R&D department is a critical component of TJL GROUP OF COMAPNY commitment to improving healthcare in Afghanistan and beyond. Through our dedication to innovation, we are working to help tackle some of the most pressing health challenges facing our communities, and to ensure that everyone has access to the life-saving treatments they need.